Pacylex News has migrated to Newsroom. Click the link below to access the latest articles and press releases.

Pacylex News

Phase I clinical experience interview with Pacylex CEO

Interview at the 2024 ASCO-GI conference, where our CEO shares the Phase 1 clinical experience with zelenirstat, our first in class, oral, cancer medicine in Phase 2. Take a look.!A0FDSkoSP1Bh

January 24, 2024